| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |